Kyle Dunnavant

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery of Potent, Orally Bioavailable Sphingosine-1-Phosphate Transporter (Spns2) Inhibitors”.

Discovery of Potent, Orally Bioavailable Sphingosine-1-Phosphate Transporter (Spns2) Inhibitors

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c00879

N/A

0DataRank · unranked

4 citations

Kyle Dunnavant, Christopher W. Shrader, Marion Q. LoPresti, Sarah Seay, Yugesh Kharel +5 more

Assessing Spns2-dependent S1P Transport as a Prospective Therapeutic Target

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.26.586765

N/A

0DataRank · unranked

1 citations

Tao Huang, Kyle Dunnavant, Daniel Foster, George M. P. R. Souza, KE Nimchuk +12 more

Assessment of Spinster homologue 2 (Spns2)‐dependent transport of sphingosine‐1‐phosphate as a therapeutic target

British Journal of Pharmacology(2025)10.1111/bph.17456

N/A

0DataRank · unranked

1 citations

Tao Huang, Kyle Dunnavant, Daniel Foster, George M. P. R. Souza, Katherine E. Nimchuk +13 more